ATU MSc International Medical Technologies, Innovation and Development

What is MSc International Medical Technologies, Innovation and Development at ATU?

EUR 32,640, about INR 36.25 lakh, is the minimum published-charge plan for MSc International Medical Technologies, Innovation and Development at ATU Galway City. The ATU MSc studies how a medical technology moves from design controls and pre-clinical evidence towards international markets. Its 35 taught ECTS cover risk, experiments,

regulation and evaluation. A 55 ECTS research project plus a CEO Masterclass complete the 90 ECTS award over 18 months. The title can sound broader than the curriculum. This is not a general biomedical engineering degree and not a clinical qualification. Its strongest academic direction is product development and commercialisation in a regulated medtech environment. Applicants looking for extensive electronics, coding or mechanical design coursework should compare the seven published modules with those expectations. Project access is central. A student already employed in medtech may propose an employer project subject to approval. A student outside medtech or life sciences must complete a year-long applied project with an industry or academic partner. ATU also publishes Galway attendance for pre-clinical practicals, project activity and evening CEO Masterclass events, so blended does not mean remote-only. The September 2026 cycle has closed. ATU’s India-facing portal shows EUR 11,000 per year after a country reduction from EUR 14,000 gross. Because the course runs for 18 months and the portal does not state one fixed whole-course invoice, the full cost is presented as a planning extension that the written offer must resolve.

How much does MSc International Medical Technologies, Innovation and Development cost for an Indian student?

The current eighteen-month planning estimate is EUR 32,640, approximately INR 36.25 lakh. It uses the India-facing EUR 11,000 annual tuition display, the Irish living-funds basis, insurance, visa, registration and application charges. The country reduction and any fee beyond one year require written confirmation.

Eighteen-month planning estimate

The living line is an immigration finance floor, not a complete Galway, Sligo or Letterkenny household budget. Converted at EUR 1 = INR 111.0585 from the European Central Bank reference rate dated 28 August 2026. INR figures are comparisons, not remittance quotes.

The India-facing application record displays EUR 11,000 per year. It also discloses a EUR 14,000 gross annual master’s fee and a EUR 3,000 country-of-origin reduction. The displayed figure is the amount used in this plan, but the offer and invoice must confirm that the reduction applies to the applicant.

The portal states the gross basis directly.

“Based on your country of origin, you may be entitled to a Country of Origin Scholarship Discount.”ATU non-EU application portal

The EUR 3,000 country reduction cannot be subtracted a second time from the displayed EUR 11,000 charge.

Irish immigration requires immediate access to at least EUR 10,000 for the first academic year on a course longer than eight months. The finance rule is evidence for a visa application, not a promise that rent, food and transport will remain within that amount.

The EUR 16,500 tuition line extends the displayed EUR 11,000 annual charge across 18 months for planning. ATU has not published it as a fixed full-programme invoice. The table also allows for insurance, visa, registration and the application fee. Flights, rent deposits, document certification, police certificates, medical tests, bank spreads and spending above the finance floor remain outside the total.

The rupee comparison uses the European Central Bank reference rate of EUR 1 = INR 111.0585 dated 28 August 2026. Bank rates and remittance charges will differ, and a later exchange-rate movement changes every INR line while leaving the euro obligation unchanged.

Part-time earnings are not a funding source for the visa case. Student work permission is conditional and does not guarantee a job, hours or pay. The family plan should therefore cover the euro total before relying on income after arrival.

Can an Indian applicant enter MSc International Medical Technologies, Innovation and Development?

The controlling academic rule is H2.2 Level 8 honours degree in a cognate science, technology or engineering discipline. English is IELTS 6.0 overall with no component below 6.0 on the programme-linked Fellows directory. ATU assesses the Indian award against the Irish Level 8 honours standard, while project, experience or registration conditions remain separate where this programme requires them.

Requirements in checking order

The programme entry section gives the course-specific route. The H2.2 Level 8 requirement is subject-specific. A transcript should make the science, technology or engineering base visible through modules, final-year work and laboratory or design evidence. A generic statement that the degree is technical leaves the cognate test unresolved.

ATU asks for a CV of no more than three pages and a motivation statement about medical technologies. A useful statement connects prior work to design control, risk, product evaluation or regulated development and identifies a research question that could be supported by an approved partner.

The ATU international entry guide provides the general India comparison. It does not waive a relevant-subject, work-experience, project or professional-registration condition published by this course. ATU’s individual assessment and written offer remain controlling.

The programme-linked Government of Ireland Fellows directory states IELTS 6.0 with no section below 6.0, stricter than ATU’s central 5.5 component floor. Use the stricter figure unless ATU provides a written programme-specific decision for the intended intake.

How should an Indian student apply for MSc International Medical Technologies, Innovation and Development?

The published deadline was 31 July 2026, intake closed, so the September 2026 closed route must not be presented as open. Use the closed cycle only as evidence of the last process, and recheck ATU before planning a later intake.

Eligibility, programme evidence, DreamApply, written offer, funding, then Irish study visa

The allowances are Nbyula planning estimates, not processing times published by Atlantic Technological University.

The official non-EU application record controls the date and route shown here. It states that the application period has ended. A later intake should not be inferred from the previous annual date.

Start with the condition most likely to stop the file, not with document collection. That may be a cognate degree, a major project arrangement, professional registration or post-degree work experience. Resolve it in writing before paying for avoidable tests, translations or deposits.

The uploaded file should keep the academic award, complete transcript, grading scale and English result readable together. Add the programme-specific CV, statement, work evidence, registration or project material where required. Documents not in English need the original and an official translation.

Read the offer as the current source for tuition, country reduction, attendance, intake and unresolved conditions. The India-facing EUR 11,000 display is not safe to assume until the applicant’s own offer and invoice reproduce it.

The Irish long-stay study visa guidance separates the immigration case from admission. Payment evidence, access to living funds, medical insurance and other supporting documents must satisfy the rules in force when the visa is filed.

What outcomes does ATU publish for MSc International Medical Technologies, Innovation and Development?

ATU links this curriculum with R&D scientist or engineer, quality and regulatory, design assurance, manufacturing, process development and clinical affairs roles. A programme-related event also involved medtech organisations, which shows industry contact. Neither fact measures recruitment, a placement percentage or the result for a defined graduating cohort.

Published evidence and its limit

Role lists and national evidence describe direction and context. They do not prove an ATU programme placement rate, salary or employment-permit result.

ATU links this curriculum with R&D scientist or engineer, quality and regulatory, design assurance, manufacturing, process development and clinical affairs roles. A programme-related event also involved medtech organisations, which shows industry contact. Neither fact measures recruitment, a placement percentage or the result for a defined graduating cohort.

Ireland’s Critical Skills framework includes specified scientists and engineers in medical-device and product-development work. Eligibility attaches to the offered occupation, duties, remuneration and qualification match. Holding this MSc alone does not make every medtech job eligible.

The 55 ECTS project can produce strong technical evidence if its question, partner and outputs align with the target role. That is an academic opportunity, not a guaranteed internship. ATU publishes no salary or employer outcome table, so the page does not calculate a return from sector averages.

Who is MSc International Medical Technologies, Innovation and Development for, and who should look elsewhere?

The strongest profile is science or engineering graduate targeting regulated medtech. The uncertain profile is cognate graduate without a medtech employer. Applicant seeking a broad biomedical engineering or clinical degree should look elsewhere because the official structure does not support that expectation.

The strongest match is science or engineering graduate targeting regulated medtech. Strong alignment with risk, regulation, evaluation and partner research.

The middle case is cognate graduate without a medtech employer. Possible, but the external or academic project setting must be resolved. The uncertainty belongs in a written ATU decision before the applicant pays a deposit or builds a visa budget.

The unsuitable case is applicant seeking a broad biomedical engineering or clinical degree. The published curriculum and award do not provide either route. This is a course-fit limit, not a judgement about the applicant’s ability.

What will you study in MSc International Medical Technologies, Innovation and Development?

ATU publishes 7 module rows totalling 90 ECTS. The largest is Research Project in Medical Technologies at 55 ECTS. The table keeps every published module and its status visible, while the current timetable, elective delivery and project arrangement still need intake-specific confirmation.

Complete published curriculum

• Complete 90 ECTS for the named Level 9 award
• Follow the current timetable and approved project arrangement
• Treat an elective as available only when ATU confirms delivery
• Meet attendance, assessment and project requirements for the selected route

The course is structured around medical technology regulation, pre-clinical evaluation and a 55 ECTS partner project. This balance matters more than the number of module titles because the largest project or dissertation determines a substantial share of the student’s time, assessment and later portfolio evidence.

The table reproduces the complete module set published on the official ATU page. ATU does not publish individual module codes there, so the code cells say that directly instead of inventing identifiers.

A catalogue table does not guarantee that an elective, project host, timetable or assessment format will remain unchanged for a later intake. The offer, registration material and current module descriptors should settle the actual academic plan before enrolment.

Should you shortlist MSc International Medical Technologies, Innovation and Development?

This programme is a credible fit for a science or engineering graduate who wants medtech product, regulatory or pre-clinical work and is comfortable making a large partner project the centre of the award. Its value lies in combining technical evidence with the regulated path towards market use.

This programme is a credible fit for a science or engineering graduate who wants medtech product, regulatory or pre-clinical work and is comfortable making a large partner project the centre of the award. Its value lies in combining technical evidence with the regulated path towards market use. This page doesn't turn a module list into a job promise. ATU hasn't published a programme placement rate, and the India-facing fee isn't guaranteed for a later cycle.

It is a poor match for someone seeking broad biomedical engineering, a clinical licence or remote study from outside Galway. The partner project and physical sessions are mandatory design features, while the programme publishes no placement rate that could justify treating the industry contact as guaranteed recruitment.

Decision checkscomplete cost · entry route · application timing · outcome evidence

Sources

These sources support the programme, admission, cost, experience and immigration information used on this page.

Sources checked on August 31, 2026. Current intake information follows. September 2026 closed.